Cécile DENIS

Publications



Articles

2023

  1. Chapron, S-A.; Kervran, C.; Da Rosa, M.; Fournet, L.; Shmulewitz, D.; Hasin, D.; Denis, C.; Collombat, J.; Monsaingeon, M.; Fatseas, M.; Gatta-Cherifi, B.; Serre, F. et al. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. In Drug and Alcohol Dependence, 251: 110937, 2023. doi 

2022

  1. Lartigau, M.; Ouattara, E.; Tumiotto, C.; Wodrich, H.; Busson, L.; Trimoulet, P.; Thiel, E.; Nouzille, M.; Dubos, M.; Lafon, M-E.; Gilleron, V.; Dehail, P. et al. Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France. In Journal of Clinical Virology, 149: 105134, 2022. doi 

2021

  1. Kervran, C.; Shmulewitz, D.; Serre, F.; Denis, C.; Roux, P.; Jauffret-Roustide, M.; Lalanne, L.; Hasin, D. and Auriacombe, M. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. In Addictive Behaviors, 116: 106797, 2021. doi 

2020

  1. Kervran, C.; Shmulewitz, D.; Serre, F.; Stohl, M.; Denis, C.; Hasin, D. and Auriacombe, M. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?. In Drug and Alcohol Dependence, 212: 108036, 2020. doi 

2019

  1. Auriacombe, M.; Roux, P.; Briand Madrid, L.; Kirchherr, S.; Kervran, C.; Chauvin, C.; Gutowski, M.; Denis, C.; Carrieri, M. P.; Lalanne, L. and Jauffret-Roustide, M. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. In BMJ Open, 9 (2): e023683, 2019. doi 

2018

  1. Auriacombe, M.; Moriceau, S.; Serre, F.; Denis, C.; Micoulaud-Franchi, J-A.; de Sevin, E.; Bonhomme, E.; Bioulac, S.; Fatseas, M. and Philip, P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. In Drug and Alcohol Dependence, 193: 1-6, 2018. doi 
  2. Serre, F.; Fatseas, M.; Denis, C.; Swendsen, J. and Auriacombe, M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. In Addictive Behaviors, 83: 123-129, 2018. doi 

2017

  1. Denis, C. M.; da Rosa, M. A. C.; Serre, F.; Kervran, C.; Henry, M.; Cherifi, B.; Auriacombe, M. and Fatseas, M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample. In Drug and Alcohol Dependence, 171: e52, 2017. doi 

2016

  1. Auriacombe, M.; Debrabant, R.; Kervran, C.; Serre, F.; Taillard, J.; Philip, P.; Denis, C. and Fatséas, M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point. In Médecine du Sommeil, 13 (3): 91-99, 2016. doi 
  2. Denis, C.; Fatséas, M.; Beltran, V.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Daulouède, J-P. and Auriacombe, M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. In Substance Abuse, 37 (1): 168-175, 2016. doi 
  3. Fatséas, M.; Hurmic, H.; Serre, F.; Debrabant, R.; Daulouède, J-P.; Denis, C. and Auriacombe, M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. In Psychiatry Research, 246: 656-662, 2016. doi 

2015

  1. Auriacombe, M.; Denis, C. M.; Rosa, M. A. C.; Collombat, J.; Serre, F.; Daulouede, J-P. and Fatseas, M. Validity of the eating section for the modified addiction severity index. In Drug and Alcohol Dependence, 156: e12, 2015. doi 
  2. Daulouède, J-P.; Denis, C. M.; Fatseas, M.; Beltran, V. and Auriacombe, M. Risk-taking behavior over 36-month follow-up treatment in outpatient opioid maintenance treatment program. In Drug and Alcohol Dependence, 146: e258, 2015. doi 
  3. Denis, C. M.; Fatseas, M.; Beltran, V.; Daulouede, J-P. and Auriacombe, M. Impact of 20 years harm reduction policy on HIV and HCV among opioid users not in treatment. In Drug and Alcohol Dependence, 146: e261, 2015. doi 
  4. Fatseas, M.; Collombat, J.; Rosa, M. A. C.; Denis, C. M.; Alexandre, J-M.; Debrabant, R.; Serre, F. and Auriacombe, M. Measuring “craving” in food addiction: Type, frequency, intensity. In Drug and Alcohol Dependence, 156: e66, 2015. doi 
  5. Rosa, M. A. C.; Collombat, J.; Denis, C. M.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatseas, M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample. In Drug and Alcohol Dependence, 156: e192, 2015. doi 

2014

  1. Auriacombe, M; Denis, C and Fatseas, M Commentary on Sharkow et al. (2014): Longitudinal patterns of problematic computer game use among adolescents and adults – a 2-year panel study. Welcomed and yet to come. Are we looking at what we are looking for?. In Addiciton, 2014.
  2. Auriacombe, M.; Denis, C. M.; Beltran, V.; Alexandre, J.; Debrabant, R.; Serre, F.; Daulouede, J-P. and Fatseas, M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use. In Drug and Alcohol Dependence, 140: e8, 2014. doi 
  3. Debrabant, R.; Fatseas, M.; Denis, C.; Taillard, J.; Philip, P. and Auriacombe, M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine. In Médecine du Sommeil, 11 (1): 34-35, 2014. doi 
  4. Denis, C. M.; Fleury, B.; Nalpas, B.; Crapelet, M. and Auriacombe, M. Correlation between severity of addiction and level of services received by alcohol use disorder outpatients in France. In Drug and Alcohol Dependence, 140: e48, 2014. doi 
  5. Fleury, B.; Denis, C. M.; Nalpas, B.; Crapelet, M. and Auriacombe, M. Patient motivation and 12-month treatment outcome in alcohol use disorder outpatients in France. In Drug and Alcohol Dependence, 140: e61, 2014. doi 

2013

  1. Fatseas, M; Denis, C; Debrabant, R; Mathillon, V; Beltran, V; Daulouède, J P; Balducci, M and Auriacombe, M Changes in Sleep Quality in Opiate-Dependent Subjects in Methadone and Buprenorphine Maintenance Treatment over a 12-month period. In Heroin Addiction and Related Clinical Problems, 15 (1): 39-44, 2013.

2012

  1. Denis, C.; Fatséas, M. and Auriacombe, M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria. In Drug and Alcohol Dependence, 122 (1-2): 22-27, 2012. doi 
  2. Denis, C.; Fatséas, M.; Beltran, V.; Bonnet, C.; Picard, S.; Combourieu, I.; Daulouède, J-P. and Auriacombe, M. Validity of the Self-Reported Drug Use Section of the Addiction Severity Index and Associated Factors Used under Naturalistic Conditions. In Substance Use & Misuse, 47 (4): 356-363, 2012. doi 
  3. Denis, C.; Langlois, E.; Fatséas, M.; Auriacombe, M. and Auriacombe, M. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels. In Psychotropes, Vol. 17 (3): 85-101, 2012. doi 
  4. Fatseas, M.; Denis, C.; Serre, F.; Dubernet, J.; Daulouède, J-P. and Auriacombe, M. Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy. In AIDS and Behavior, 16 (7): 2082-2090, 2012. doi 
  5. Malivert, M.; Fatséas, M.; Denis, C.; Langlois, E. and Auriacombe, M. Effectiveness of Therapeutic Communities: A Systematic Review. In European Addiction Research, 18 (1): 1-11, 2012. doi 
  6. ROSSARD, P.; RIUNE-LACABE, S.; COUSIN, P.; DENIS, C. and AURIACOMBE, M. Consommation de substances et comportements à risque au cours de l'incarcération: Enquête dans une maison d'arrêt en France. In Le Courrier des addictions, 14 (2), 2012.
  7. Serre, F; Denis, C; Fatseas, M and Auriacombe, M Santé, travail et addiction. In Le Courrier des Addictions, 14: 22-23, 2012.

2011

  1. Fatseas, M.; Denis, C.; Massida, Z.; Verger, M.; Franques-Rénéric, P. and Auriacombe, M. Cue-Induced Reactivity, Cortisol Response and Substance Use Outcome in Treated Heroin Dependent Individuals. In Biological Psychiatry, 70 (8): 720-727, 2011. doi 

Collections

2018

  1. Auriacombe, M.; Serre, F.; Denis, C. and Fatséas, M. Diagnosis of Addictions. In The Routledge Handbook of Philosophy and Science of Addiction, pages 132-144, Routledge, 1 [edition]. | New York : Routledge, 2018. | Series: Routledge handbooks in philosophy, 2018.

2016

  1. Denis, C.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatséas, M. 38. Outils d'évaluation pour les addictions. In Traité d'addictologie, 2016.

2014

  1. Fatséas, M.; Denis, C. and Auriacombe, M. Chapitre 14. Héroïne et opiacés. In Addictions et comorbidités, pages 237-247, Dunod, 2014.

2013

  1. Denis, C.; Lavie, E.; Fatseas, M. and Auriacombe, M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. In Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, Chichester, UK, 2013.

2012

  1. Fatseas, M; Denis, C; Alexandre, J-M. and Auriacombe, M Les critères diagnostiques de la dépendance aux substances psycho-actives sont-ils valides pour le diagnostic du jeu pathologique ?. In Le jeu pathologique. Comprendre-Prévenir-Traiter, pages 101-105, Masson, Paris, Congrès de psychiatrie et de neurologie de langue française , 2012.

Misc

2015

  1. Denis, C. M.; Metzger, D.; Huang, L.; Trias, V.; Auriacombe, M.; Raguin, G.; Hoai, S. M. T.; Le Truong, G.; Daulouede, J-P. and O'Brien, C. P. A 6-month follow-up of the integrated treatment for opiate addiction and HIV in Vietnam. doi  WWW 

2014

  1. Auriacombe, M.; Denis, C. and Fatséas, M. Commentary on Scharkow etal. (2014): Welcomed and yet to come. Are we looking at what we are looking for?. doi 

 

 

 

 

 

 


Université de Bordeaux CNRS

CNRS UMR 6033



Participez à une étude...

A noter

Congrès 2024: ALBATROS, CPDD, Fédération Addiction...


Directeur

Pr. Marc Auriacombe

Directeur adjoint

J. Taillard

Administration :

Tel : +33 (0)5 57 82 01 73

Bureau Recherche Sommeil

Tel : +33 (0)5 57 82 01 82

Bureau Recherche Addiction

Tel : +33 (0)5 56 56 17 67

Adresse :

UMR 6033 SANPSY
CHU Pellegrin, Tripode
13ème étage, aile 3
Place Amélie- Raba-Léon
33076 Bordeaux cédex
France

logo SANPSY Accéder au laboratoire


Investissement d'Avenir Clinilabs Certified Site Clinilabs Certified Site